The authors reply

We would like to thank Tan et  al.1 for validating and confirming our antineutrophil cytoplasm antibody (ANCA) renal risk score.2 In a retrospective, single-center London cohort of 178 patients, the score determined renal survival dependent on patients’ risk groups at the 36-month follow-up (P 
Source: Kidney International - Category: Urology & Nephrology Authors: Tags: Letter to the Editor Source Type: research